A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Recruiting · NCT06499350 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors | Advanced Malignant Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-09-04 | NCT06499350 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| FindCure Biosciences (ZhongShan) Co., Ltd. | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai East Hospital | Shanghai | China | 38 |